[Practical use of the TDF factor in radiotherapy of basalioma and squamous cell carcinoma]
- PMID: 1428870
[Practical use of the TDF factor in radiotherapy of basalioma and squamous cell carcinoma]
Abstract
For X-ray therapy, the relation between single doses, number of fractions and duration of therapy have been combined in the TDF (time, dose, fraction) factor by Orton and Ellis. This factor seems to be well suited to evaluation of the X-ray therapy of basal cell carcinomas and squamous cell carcinomas of the skin. A simplified TDF formula is presented, together with some methods of calculation. Furthermore, tables are presented containing TDF values for frequently applied single doses and for two to five fractions per week. In addition, some hints are given on the use of the decay factor of Orton and Ellis to compensate for the loss of X-ray effectiveness if therapy has been interrupted.
Similar articles
-
[Use of the TDF factor in soft roentgen radiotherapy].Hautarzt. 1989 Dec;40(12):774-7. Hautarzt. 1989. PMID: 2695500 Clinical Trial. German.
-
Soft x-ray therapy for cutaneous basal cell and squamous cell carcinomas.J Am Acad Dermatol. 2005 Dec;53(6):993-1001. doi: 10.1016/j.jaad.2005.07.045. J Am Acad Dermatol. 2005. PMID: 16310060
-
Further histochemical studies on cellular response of human skin cancer in the course of fractionated X-ray therapy.Radiobiol Radiother (Berl). 1971;12(5):547-58. Radiobiol Radiother (Berl). 1971. PMID: 5145339 No abstract available.
-
Treatment of basal cell carcinoma and squamous cell carcinoma with perineural invasion.Adv Dermatol. 1993;8:277-304; discussion 305. Adv Dermatol. 1993. PMID: 8240916 Review. No abstract available.
-
Radiotherapy for cutaneous squamous and basal cell carcinomas of the head and neck.Laryngoscope. 2009 Oct;119(10):1994-9. doi: 10.1002/lary.20608. Laryngoscope. 2009. PMID: 19688856 Review.
Publication types
MeSH terms
LinkOut - more resources
Medical